Insights

In-depth interviews with decision-makers, stakeholders, and researchers on timely and emerging trends in clinical data, health policy, value-based care, and more!

Heart Failure With Preserved Ejection Fraction: Current Status and Future Opportunities

January 26th 2021Heart Failure With Preserved Ejection Fraction: Current Status and Future Opportunities

Key opinion leaders discuss the key differences and unmet needs in disease management for heart failure with preserved ejection fraction and heart failure with reduction ejection fraction.

Deepu Madduri, MD

January 25th 2021CAR T-Cell Therapy for the Management of Multiple Myeloma

Oncologists explore the opportunity of CAR T-cell therapy for the treatment of relapsed/refractory multiple myeloma.

Lee Schwartzberg, MD, FACP

January 18th 2021New Directions in Chemotherapy-Induced Neutropenia

A clinician and payer discuss the impact of chemotherapy-induced neutropenia on patients as well as the healthcare system, and discuss the latest in prophylactic treatment, especially during the COVID-19 pandemic.

Sarah Sammons

January 14th 2021Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer

Examining current treatment options for brain metastases in metastatic HER2+ breast cancer and assessing the clinical and economic burden.

Challenges and Opportunities for Patients With HIV During COVID-19

December 4th 2020Challenges and Opportunities for Patients With HIV During COVID-19

The impact of the COVID-19 pandemic on managing HIV and strategies implemented to address challenges faced by providers.

Current and Future Treatments for the Management of Myelodysplastic Syndrome

August 13th 2020Current and Future Treatments for the Management of Myelodysplastic Syndrome

Employer Opportunities With Biosimilars

August 11th 2020Employer Opportunities With Biosimilars

Understanding the Subpopulations of Pulmonary Hypertension

April 15th 2020Understanding the Subpopulations of Pulmonary Hypertension

Migraine Management: The Business Case

March 31st 2020Migraine Management: The Business Case

Management of Advanced Fibrosis due to Non-Alcoholic SteotoHepatitis

February 24th 2020Management of Advanced Fibrosis due to Non-Alcoholic SteotoHepatitis

Management of Diabetic Retinopathy

December 24th 2019Management of Diabetic Retinopathy

Emerging Agents for Basal Cell Carcinoma and Cutaneous Squamous-Cell Carcinoma

December 19th 2019Emerging Agents for Basal Cell Carcinoma and Cutaneous Squamous-Cell Carcinoma

Emerging Therapies for Interstitial Lung Disease

July 24th 2019Emerging Therapies for Interstitial Lung Disease

Biologics for the Treatment of Adolescent Atopic Dermatitis

May 30th 2019Biologics for the Treatment of Adolescent Atopic Dermatitis

Understanding Multiple Sclerosis and the Treatment Advances

April 15th 2019Understanding Multiple Sclerosis and the Treatment Advances

Non–Small Cell Lung Cancer Clinical Care

March 15th 2019Non–Small Cell Lung Cancer Clinical Care

Emerging Agents for Myelofibrosis

December 28th 2018Emerging Agents for Myelofibrosis

Understanding Axial Spondyloarthritis

December 27th 2018Understanding Axial Spondyloarthritis

Patient Selection and Safety With TNF Inhibitors

November 26th 2018Patient Selection and Safety With TNF Inhibitors

Advances in the Treatment of Hyperhidrosis

August 2nd 2018Advances in the Treatment of Hyperhidrosis

Current Treatment Regimens for Multiple Myeloma

July 25th 2018Current Treatment Regimens for Multiple Myeloma

Antiangiogenic Therapy: Appropriate Therapeutic Options and Sequencing in NSCLC

July 18th 2018Antiangiogenic Therapy: Appropriate Therapeutic Options and Sequencing in NSCLC

Personalized Selection of Upfront Therapy in CLL

July 11th 2018Personalized Selection of Upfront Therapy in CLL

PARP Inhibitors in the Management of Ovarian Cancer

November 28th 2017PARP Inhibitors in the Management of Ovarian Cancer

Perspectives in the Management of Non-Small Cell Lung Cancer

May 12th 2017Perspectives in the Management of Non-Small Cell Lung Cancer

Use of Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation

April 18th 2017Use of Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation

Clinical Progress and Coverage Policies in Immuno-Oncology

July 28th 2016Clinical Progress and Coverage Policies in Immuno-Oncology

Updates in the Treatment of Pulmonary Arterial Hypertension

July 18th 2016Updates in the Treatment of Pulmonary Arterial Hypertension

Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

July 18th 2016Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care

Current Clinical Landscape and Managed Care Approach in Multiple Myeloma

July 6th 2016Current Clinical Landscape and Managed Care Approach in Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions